Fortified with a deep understanding of intellectual property and technology transactions, we work with brands at all stages of the advertising lifecycle.
Through our global platform, we help clients substantiate and clear global advertising, marketing, and promotional campaigns— whether traditional print or television, digital content on websites, or social media. Our advertising practice further supports media agencies and media technology providers in crafting and negotiating complex engagements and creating compliance protocols.
We provide our clients with goal-focused counseling. This includes counsel regarding brand selection and protection, brand use guidelines, advertising policies, compliance programs, and advertising campaign strategies. Our experienced advertising and marketing lawyers also provide guidance regarding ad claim review, guiding clients on matters such as product labelling and claim substantiation issues. We help our clients with advertising disputes and challenges, including government enforcement actions, federal and state law claims, and self-regulatory matters. Our lawyers can also handle a broad spectrum of sponsorship, endorsement, and sweepstakes-related legal matters.
We can help clients with a wide variety of advertising and marketing issues, including:
Competitor false and misleading advertising, including Lanham Act cases, National Advertising Division (NAD) Proceedings, and state unfair competition and deceptive trade practices
Consumer false advertising and deceptive trade practices
Food, drug, device, and cosmetic regulation and compliance
Federal Trade Commission (FTC) advertising regulations and investigations
Consumer Finance Protection Bureau
Data usage, privacy, and security
Advertising agencies
Telemarketing and Telephone Consumer Protection Act (TCPA)
This alert provides a brief overview of the final rules and the potential policy tools available to the Biden administration should it seek to revisit them.
On 23 December 2020, Judge Catherine Blake of the U.S. District Court for the District of Maryland granted the Pharmaceutical Research and Manufacturers of America (PhRMA) a 14-day nationwide temporary restraining order, preventing the Centers for Medicare and Medicaid Services (CMS) from implementing and enforcing its Most Favored Nation (MFN) interim final rule (MFN Rule) scheduled to take effect on 1 January 2021.
Following earlier announcements as to the efficacy of vaccine trials by pharmaceutical companies Pfizer, Inc. (Pfizer) and Moderna, Inc. on November 20, 2020, Pfizer and BioNTech submitted applications for emergency use authorization to the U.S. Food and Drug Administration (FDA) for their COVID-19 vaccinations.
The Australian Government has announced a number of changes to its migration policies in September in response to the ongoing COVID-19 pandemic. This alert collates some of the recently announced changes that are most relevant to employers in Australia.
We welcome your email, but please understand that if you are not already a client of K&L Gates LLP, we cannot represent you until we confirm that doing so would not create a conflict of interest and is otherwise consistent with the policies of our firm. Accordingly, please do not include any confidential information until we verify that the firm is in a position to represent you and our engagement is confirmed in a letter. Prior to that time, there is no assurance that information you send us will be maintained as confidential. Thank you for your consideration.
